SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-174259
Filing Date
2020-06-19
Accepted
2020-06-19 17:26:24
Documents
4
Period of Report
2020-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d946838d8k.htm 8-K 32366
2 EX-99.1 d946838dex991.htm EX-99.1 199595
3 GRAPHIC g946838g0612093802401.jpg GRAPHIC 649
4 GRAPHIC g946838g0612093803769.jpg GRAPHIC 3485
  Complete submission text file 0001193125-20-174259.txt   239122
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 20976609
SIC: 2836 Biological Products, (No Diagnostic Substances)